Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson's disease. Pilot study.

被引：0
|
作者：
Nevrly, M. [1 ]
Ressner, P. [1 ]
Nestrasil, I. [1 ]
Vranova, H. [1 ]
Herzig, R. [1 ]
Kanovsky, P. [1 ]
机构：
[1] Palacky Univ, Dept Neurol, Univ Hosp, CR-77147 Olomouc, Czech Republic
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [41] Entacapone: useful adjunct to levodopa for Parkinson’s disease, but no comparative data
    Drugs & Therapy Perspectives, 2000, 15 (11) : 1 - 4
  • [42] Plasma levodopa level treated with levodopa in combination with carbidopa or benserazide in Parkinson's disease
    Nomoto, M
    Nagai, M
    Yabe, H
    Nakatsuka, A
    Moritoyo, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 118P - 118P
  • [43] Levodopa, homocysteine and Parkinson?s disease: What?s the problem?
    Ahlskog, J. Eric
    PARKINSONISM & RELATED DISORDERS, 2023, 109
  • [44] Optimization of use of levodopa in Parkinson's disease:: role of levodopa-carbidopa-entacapone combination
    Castro, A
    Valldeoriola, F
    Linazasoro, G
    Rodriguez-Oroz, MC
    Stochi, F
    Marín, C
    Rodríguez, M
    Vaamonde, J
    Jenner, P
    Alvarez, L
    Pavón, N
    Macías, R
    Luquín, MR
    Hernández, B
    Grandas, F
    Giménez-Roldán, S
    Tolosa, ES
    Obeso, EJ
    NEUROLOGIA, 2005, 20 (04): : 180 - 188
  • [45] Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone
    Park, Jongkyu
    Kim, Younsoo
    Youn, Jinyoung
    Lee, Phil H.
    Sohn, Young H.
    Koh, Seoung B.
    Lee, Jee-Young
    Baik, Jong S.
    Cho, Jin W.
    NEUROLOGY INDIA, 2017, 65 (04) : 746 - 751
  • [46] Levodopa effect on experimental pain in Parkinson's disease: A clinical and neuroimaging pilot study
    Brefel-Courbon, C
    Payoux, P
    Quelven, I
    Claire, T
    Galitzky, M
    Montastruc, JL
    MOVEMENT DISORDERS, 2002, 17 : S46 - S46
  • [47] Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
    Senek, Marina
    Nielsen, Elisabet I.
    Nyholm, Dag
    MOVEMENT DISORDERS, 2017, 32 (02) : 283 - 286
  • [48] Levodopa-entacapone-carbidopa intestinal gel infusion for Parkinson's disease: An analysis of data collected from the Swedish national register of Parkinson's disease.
    Othman, M.
    Odin, P.
    Bergquist, F.
    Johansson, A.
    Constantinescu, R.
    Scharfenort, M.
    Widner, H.
    Nyholm, D.
    MOVEMENT DISORDERS, 2023, 38 : S618 - S618
  • [49] Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study
    Caraceni, T
    Musicco, M
    PARKINSONISM & RELATED DISORDERS, 2001, 7 (02) : 107 - 114
  • [50] Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment
    Zhang, Li
    Yuan, Yongsheng
    Tong, Qing
    Jiang, Siming
    Xu, Qinrong
    Ding, Jian
    Zhang, Lian
    Zhang, Rui
    Zhang, Kezhong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (07) : 630 - 636
12345